Edwards Lifesciences Corporation (EW)Healthcare | Medical Devices | Irvine, United States | NYSE
85.27 USD
-1.12
(-1.296%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 84.52 -0.75 (-0.746%) ⇩ (Oct. 13, 2026, 8 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 8:59 a.m. EDT
The business shows strong resilience despite a recent earnings miss, with revenue growth holding steady at thirteen percent while operating margins remain robust near thirty percent. The market is pricing in a significant earnings recovery, evidenced by the forward multiple compressing to twenty-five times earnings compared to the trailing fifty times. While the stock trades below its fifty-day average, indicating short-term weakness, the balance sheet is fortified with a current ratio of four point five and ample free cash flow. The options market is leaning bullish for the coming months, betting on a continuation of the recovery. This appears to be a high-quality compounder currently navigating a temporary earnings headwind rather than a structural decline. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.061297 |
| MSTL | 0.062103 |
| AutoTheta | 0.062812 |
| AutoARIMA | 0.063840 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 55% |
| H-stat | 0.30 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.457 |
| Excess Kurtosis | -0.89 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 6.568 |
| Revenue per Share | 11.223 |
| Market Cap | 49,098,465,280 |
| Trailing P/E | 50.76 |
| Forward P/E | 25.25 |
| Beta | 0.86 |
| Profit Margins | 15.43% |
| Website | https://www.edwards.com |
As of Oct. 10, 2026, 8:59 a.m. EDT: Speculators are positioning for upside with call open interest significantly outweighing put open interest in the November and December 2026 expirations, particularly at the 100 strike. While deep out-of-the-money puts carry inflated implied volatility suggesting a hedge against a sharp drop, the volume skew favors a bullish outcome.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.17761719 |
| Address1 | One Edwards Way |
| All Time High | 131.73 |
| All Time Low | 1.0 |
| Ask | 0.0 |
| Ask Size | 100 |
| Audit Risk | 4 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 3,771,420 |
| Average Daily Volume3 Month | 3,844,693 |
| Average Volume | 3,844,693 |
| Average Volume10Days | 3,771,420 |
| Beta | 0.864 |
| Bid | 0.0 |
| Bid Size | 400 |
| Board Risk | 2 |
| Book Value | 18.415 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 85.27 |
| Current Ratio | 4.522 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 86.77 |
| Day Low | 85.07 |
| Debt To Equity | 6.568 |
| Display Name | Edwards Lifesciences |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,822,400 |
| Earnings Call Timestamp Start | 1,793,822,400 |
| Earnings Growth | -0.254 |
| Earnings Quarterly Growth | -0.274 |
| Earnings Timestamp | 1,793,822,400 |
| Earnings Timestamp End | 1,793,822,400 |
| Earnings Timestamp Start | 1,793,822,400 |
| Ebitda | 1,996,800,000 |
| Ebitda Margins | 0.30662 |
| Enterprise To Ebitda | 22.891 |
| Enterprise To Revenue | 7.019 |
| Enterprise Value | 45,708,226,560 |
| Eps Current Year | 2.99923 |
| Eps Forward | 3.37714 |
| Eps Trailing Twelve Months | 1.68 |
| Esg Populated | 0 |
| Exchange | NYQ |
| Exchange Data Delayed By | 20 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 88.6254 |
| Fifty Day Average Change | -3.3554 |
| Fifty Day Average Change Percent | -0.03786048 |
| Fifty Two Week Change Percent | 17.761719 |
| Fifty Two Week High | 96.29 |
| Fifty Two Week High Change | -11.020004 |
| Fifty Two Week High Change Percent | -0.114445984 |
| Fifty Two Week Low | 72.4 |
| Fifty Two Week Low Change | 12.869995 |
| Fifty Two Week Low Change Percent | 0.17776236 |
| Fifty Two Week Range | 72.4 - 96.29 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 954,167,400,000 |
| Float Shares | 574,492,116 |
| Forward Eps | 3.37714 |
| Forward P E | 25.249174 |
| Free Cashflow | 1,232,412,544 |
| Full Exchange Name | NYSE |
| Full Time Employees | 16,000 |
| Fullday Change | -1.1200027 |
| Fullday Change Percent | -1.2964495 |
| Fullday Price | 85.27 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.77839 |
| Gross Profits | 5,069,100,032 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00195 |
| Held Percent Institutions | 0.95596004 |
| Implied Shares Outstanding | 575,800,000 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://ir.edwards.com/ |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,590,969,600 |
| Last Split Factor | 3:1 |
| Long Business Summary | Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. |
| Long Name | Edwards Lifesciences Corporation |
| Market | us_market |
| Market Cap | 49,098,465,280 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_411220 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 979,900,032 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 50,043,048,000 |
| Number Of Analyst Opinions | 26 |
| Open | 86.55 |
| Operating Cashflow | 1,720,300,032 |
| Operating Margins | 0.29839 |
| Overall Risk | 2 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.84 |
| Phone | 949 250 2500 |
| Post Market Change | -0.7463989 |
| Post Market Change Percent | -0.87533593 |
| Post Market Price | 84.5236 |
| Post Market Time | 1,791,936,000 |
| Previous Close | 86.39 |
| Price Eps Current Year | 28.43063 |
| Price Hint | 2 |
| Price To Book | 4.630464 |
| Price To Sales Trailing12 Months | 7.5393434 |
| Profit Margins | 0.15431 |
| Quick Ratio | 3.454 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.58621 |
| Region | US |
| Regular Market Change | -1.12 |
| Regular Market Change Percent | -1.29645 |
| Regular Market Day High | 86.77 |
| Regular Market Day Low | 85.07 |
| Regular Market Day Range | 85.07 - 86.77 |
| Regular Market Open | 86.55 |
| Regular Market Previous Close | 86.39 |
| Regular Market Price | 85.27 |
| Regular Market Time | 1,791,921,603 |
| Regular Market Volume | 3,642,969 |
| Return On Assets | 0.083680004 |
| Return On Equity | 0.09175 |
| Revenue Growth | 0.136 |
| Revenue Per Share | 11.223 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 575,800,000 |
| Shares Percent Shares Out | 0.0165 |
| Shares Short | 9,538,735 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 9,022,064 |
| Short Name | Edwards Lifesciences Corporatio |
| Short Percent Of Float | 0.0188 |
| Short Ratio | 2.78 |
| Source Interval | 15 |
| State | CA |
| Symbol | EW |
| Target High Price | 110.0 |
| Target Low Price | 84.0 |
| Target Mean Price | 101.96154 |
| Target Median Price | 102.5 |
| Total Cash | 4,252,699,904 |
| Total Cash Per Share | 7.378 |
| Total Debt | 704,400,000 |
| Total Revenue | 6,512,300,032 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.68 |
| Trailing P E | 50.75595 |
| Trailing Peg Ratio | 1.8519 |
| Triggerable | 1 |
| Two Hundred Day Average | 85.13875 |
| Two Hundred Day Average Change | 0.13124847 |
| Two Hundred Day Average Change Percent | 0.0015415833 |
| Type Disp | Equity |
| Volume | 3,642,969 |
| Website | https://www.edwards.com |
| Zip | 92,614 |